AUM $56.9MER 0.99%NAV $38.21Holdings 46Inception Nov 2023
Price Chart
Key Statistics
Previous Close
$38.77Day Range
$38.37$38.57
52-Week Range
$29.46$38.87
Avg Volume
2.9KDividend Yield
1.36%Expense Ratio
0.99%AUM
$56.9MShares Outstanding
1.5METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 78.50% |
| Switzerland | 6.85% |
| Denmark | 5.93% |
| United Kingdom | 2.88% |
| Ireland | 2.11% |
| Japan | 1.08% |
| Israel | 1.07% |
| Canada | 0.87% |
| Other | 0.71% |
Fund Information
- Issuer
- Tema
- Category
- Healthcare
- Types
- Biotech
- Inception Date
- Nov 19, 2023
- Exchange
- NASDAQ
- Description
- The Tema Heart & Health ETF (HRTS) seeks to invest in companies that potentially stand to benefit from further advances in biotechnology and healthcare, specifically companies involved in cardiology, metabolic diseases and weight loss therapies.
Similar ETFs
The Tema Cardiovascular and Metabolic ETF (HRTS) is an exchange-traded fund issued by Tema that launched on Nov 19, 2023. It currently manages $56.9M in assets under management. The fund charges an expense ratio of 0.99%. The fund holds 46 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 48.9% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & CO | 11.68% | 5,343 | $6.6M |
| 2 | TMO | THERMO FISHER SCIENTIFIC INC | 5.09% | 4,616 | $2.9M |
| 3 | NOVO-B.CO | NOVO NORDISK A/S | 5.01% | 61,668 | $2.9M |
| 4 | UNH | UNITEDHEALTH GROUP INC | 4.86% | 7,195 | $2.8M |
| 5 | MRK | MERCK & CO INC | 4.25% | 16,233 | $2.4M |
| 6 | RHHBY | ROCHE HOLDING AG | 3.92% | 38,978 | $2.2M |
| 7 | JNJ | JOHNSON & JOHNSON | 3.84% | 8,166 | $2.2M |
| 8 | RVMD | REVOLUTION MEDICINES INC | 3.70% | 9,951 | $2.1M |
| 9 | CYTK | CYTOKINETICS INC | 3.45% | 25,425 | $2.0M |
| 10 | ABT | ABBOTT LABORATORIES | 3.13% | 15,601 | $1.8M |
| 11 | BBIO | BRIDGEBIO PHARMA INC | 3.11% | 21,343 | $1.8M |
| 12 | GILD | GILEAD SCIENCES INC | 2.99% | 11,884 | $1.7M |
| 13 | DHR | DANAHER CORP | 2.94% | 7,756 | $1.7M |
| 14 | NOVN.SW | NOVARTIS AG | 2.93% | 10,564 | $1.7M |
| 15 | VRTX | VERTEX PHARMACEUTICALS INC | 2.92% | 3,079 | $1.7M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -1.02% | |
| 1W | +1.43% | |
| 1M | +4.25% | |
| 3M | +11.23% | |
| 6M | +6.32% | |
| YTD | +9.08% | |
| 1Y | +30.22% | |
| 3Y | +44.11% | |
| 5Y | +44.11% |
Moving Averages
20-Day MA
$37.50
Above 20-Day MA50-Day MA
$36.61
Above 50-Day MA200-Day MA
$35.07
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$38.87
Current Price
$38.37
52-Week Low
$29.46
$29.46$38.87
Current Yield
1.36%
Annual Dividend
$1.8844
Frequency
Annualx/year
Last Ex-Date
Dec 10, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 10, 2025 | $0.4729 | Dec 11, 2025 |
| Dec 10, 2025 | $0.4729 | Dec 11, 2025 |
| Dec 11, 2024 | $0.4693 | Dec 12, 2024 |
| Dec 11, 2024 | $0.4693 | Dec 12, 2024 |
Dividend Payments Over Time
Category Comparison
| Metric | HRTS | Healthcare(223 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.99% | 0.62% | 0.84% |
| AUM | $56.9M | $1.98B | $1.86B |
| Dividend Yield | 1.36% | 3.90% | 1.97% |
| Avg Volume | 2.9K | 422.1K | 1.1M |
| Holdings | 46 | 167 | 65 |
| Performance | |||
| 1-Month Return | +6.40% | +6.56% | +11.19% |
| 6-Month Return | +13.26% | +16.09% | +26.77% |
| YTD Return | +9.86% | +16.75% | +27.34% |
| 1-Year Return | +9.02% | +15.10% | +23.91% |
Compare with Another ETF
Search for an ETF to compare with HRTS:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.